Skip to main content

Table 3 Haemoptysis recurrences and their severity in 103 patients related to the final diagnosis

From: Long-term prognostic outcomes in patients with haemoptysis

Final diagnosis

Events

Patients

Mild

Moderate

Severe

Bronchiectasis, n (%)

45

28 (27.2)

20 (71.4)

6 (21.4)

2 (7.1)

Pulmonary malignancy, n (%)

30

24 (23.3)

11(36.6)

11 (36.6)

2 (0.8)

 Lung cancer, n (%)

26

22 (21.4)

10 (45.5)

10 (45.5)

2 (9.1)

 Pulmonary metastasis, n (%)

4

2 (1.9)

1 (50.0)

1 (50.0)

0 (0.0)

Pneumonia/lung abscess, n (%)

21

13 (12.6)

13 (100)

0 (0.0)

0 (0.0)

COPD (exacerbation), n (%)

13

7 (6.8)

7 (100.0)

0 (0.0)

0 (0.0)

Acute bronchitis, n (%)

11

7 (6.8)

7 (100.0)

0 (0.0)

0 (0.0)

Cryptogenic haemoptysis, n (%)

10

6 (5.8)

5 (83.3)

1 (16.7)

0 (0.0)

Upper airways bleeding disease, n (%)

8

4 (3.9)

2 (50.0)

2 (50.0)

0 (0.0)

Post-tuberculosis sequelae, n (%)

8

3 (2.9)

2 (66.7)

1 (33.3)

0 (0.0)

Other pulmonary/bronchial vascular lesion, n (%)

5

2 (1.9)

1 (50.0)

0 (0.0)

1 (50.0)

Pulmonary embolism, n (%)

5

2 (1.9)

1 (50.0)

1 (50.0)

0 (0.0)

Atypical mycobacteriosis, n (%)

2

1 (1.0)

1 (100.0)

0 (0.0)

0 (0.0)

Active tuberculosis, n (%)

2

2 (1.9)

1 (50.0)

1 (50.0)

0 (0.0)

Iatrogenic or traumatic, n (%)

2

1 (1.0)

1 (100.0)

0 (0.0)

0 (0.0)

Tracheal granuloma, n (%)

2

1 (1.0)

1 (100.0)

0 (0.0)

0 (0.0)

Hematemesis, n (%)

1

1 (1.0)

0 (0.0)

1 (100.0)

0 (0.0)

Interstitial lung disease, n (%)

1

1 (1.0)

1 (100.0)

0 (0.0)

0 (0.0)

  1. COPD chronic obstructive pulmonary disease